| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 200 | 100 | 199 | 1.378 | 1.002 | 397 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 200 | 100 | 199 | 1.378 | 1.002 | 397 | 0 |
| Total Expenses - EUR | 0 | 0 | 0 | 4.082 | 4.181 | 1.626 | 2.606 | 2.159 | 1.862 | 1.300 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | -3.882 | -4.081 | -1.427 | -1.228 | -1.157 | -1.465 | -1.300 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | -3.888 | -4.084 | -1.432 | -1.270 | -1.187 | -1.465 | -1.300 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - New Bio Life Nbl S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 5.823 | 5.829 | 4.838 | 3.988 | 3.151 | 3.869 |
| Current Assets | 3.023 | 2.992 | 2.942 | 90 | 826 | 975 | 1.089 | 1.096 | 1.112 | 971 |
| Inventories | 2.935 | 2.905 | 2.856 | 0 | 695 | 681 | 666 | 723 | 666 | 663 |
| Receivables | 88 | 87 | 86 | 83 | 81 | 279 | 273 | 243 | 173 | 172 |
| Cash | 0 | 0 | 0 | 7 | 51 | 15 | 150 | 130 | 272 | 136 |
| Shareholders Funds | -906 | -897 | -882 | -4.753 | -8.745 | -10.011 | -11.059 | -12.280 | -13.708 | -14.932 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.929 | 3.889 | 3.823 | 4.843 | 15.394 | 16.815 | 16.985 | 17.364 | 17.971 | 19.772 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
4775
|
|||||||||
Comments - New Bio Life Nbl S.r.l.